These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8869815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
    Xu X, Tang BK, Pang KS.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.
    Morris ME, Yuen V, Tang BK, Pang KS.
    J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. First-pass metabolism of gentisamide: influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation.
    Hirayama H, Pang KS.
    Drug Metab Dispos; 1990 May; 18(5):580-7. PubMed ID: 1981705
    [Abstract] [Full Text] [Related]

  • 8. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
    Pang KS, Koster H, Halsema IC, Scholtens E, Mulder GJ, Stillwell RN.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
    [Abstract] [Full Text] [Related]

  • 9. Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.
    Geng W, Pang KS.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):597-606. PubMed ID: 9918564
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
    Dawson JR, Weitering JG, Mulder GJ, Stillwell RN, Pang KS.
    J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
    Chiba M, Schwab AJ, Goresky CA, Pang KS.
    Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
    [Abstract] [Full Text] [Related]

  • 20. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.
    Xu X, Selick P, Pang KS.
    J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.